No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
CERo Therapeutics CERO Clinical Trial Site; PMGC Holdings ENSC Exercise of Warrants
CERo Therapeutics Stock Spikes 42% On Clinical Trial Site Announcement For AML Treatment
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook
CERo Therapeutics Holdings Shares Are Trading Higher After the Company Announced the Key Clinical Trial Site Location for Its Phase 1 CER-1236 Trial.
12 Health Care Stocks Moving In Thursday's Pre-Market Session